Ben-Gurion University of the Negev (BGU) and University of Colorado researchers have developed a dynamic “smart” drug that targets inflammation in a site-specific manner and could enhance the body’s natural ability to fight infection and reduce side effects.
The uniqueness of this novel anti-inflammatory molecule, reported in the current issue of Journal of Immunology, can be found in a singular property. When injected, it is as a non-active drug. However, a localized site with excessive inflammation will activate it. Most other anti-inflammatory agents effectively inhibit inflammatory processes, though in a non-specific manner and in areas that include sites of necessary normal inflammatory homeostasis.
“This development is important because inhibition of inflammation in a non-specific manner reduces the natural ability to fight infections and is a common side effect of anti-inflammatory biologic therapeutics,” says Dr. Peleg Rider of BGU’s Department of Clinical Biochemistry and Pharmacology.
When a non-specific agent is used, any patient who suffers from local inflammation might then be exposed to opportunistic infections at distant sites, such as lungs, risking, for example, tuberculosis. This risk is mainly of concern to immunosuppressed patients, as well as older patients and patients undergoing chemotherapy as part of an anti-cancer treatment course.
“The beauty of this invention lies in the use of a known natural biological code,” Dr. Rider explains. “We mimicked a natural process that occurs during inflammation.”
The protein molecule is actually a chimera comprised of two domains, both originating from the potent inflammatory cytokine family of IL-1. The first part of the protein holds the functional part of the molecule inactive, as occurs in normal living cells, and is connected to a potent natural inhibitor of IL-1. When it encounters inflammatory enzymes, the molecule is cleaved and the functional part becomes active.
The Latest on: Inflammation Research
via Google News
The Latest on: Inflammation Research
- Birmingham Research Brings Hope For Spinal Cord Injury Treatment'on May 20, 2022 at 2:43 am
Scientists from the University of Birmingham have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord. Their research, ...
- Research brings hope for spinal cord injury treatmenton May 20, 2022 at 1:19 am
Scientists from the University of Birmingham, U.K., have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord.
- Dietary cholesterol worsens inflammation, sickness in mice with influenzaon May 19, 2022 at 1:38 pm
New research from the University of Illinois suggests high levels of dietary cholesterol make mice sicker when they are infected with influenza. The study is the first to link cholesterol in the diet ...
- Cross-talking neurons spill secrets of inflammation spread in arthritison May 18, 2022 at 11:58 pm
As the underlying cause of rheumatoid arthritis and other autoimmune disorders, there is considerable interest in deepening our understanding of chronic inflammation and the way it takes hold in the ...
- New research may explain unexpected effects of common painkillerson May 18, 2022 at 8:00 am
New research may help explain why common anti-inflammatory drugs like ibuprofen have unexpected effects on heart disease, cancer, and more.
- ATP from sensory neuron-interneuron crosstalk is key to spreading inflammation in Rheumatoid Arthritison May 17, 2022 at 7:03 am
Adenosine triphosphate (ATP) secreted from sensory neuron-interneuron crosstalk is key to the spreading of inflammation across joints, acting as a neurotransmitter and inflammation enhancer.
- New Target Discovered for Non-Type 2 Inflammation in Severe Asthmaon May 17, 2022 at 3:07 am
Genentech researchers identify oncostatin M as a protein that may be responsible for the severe airway inflammation seen in patients with noneosinophilic asthma.
- Research reveals how a leaky gut leads to inflammation in the lungson May 11, 2022 at 3:21 pm
Why are older adults more likely to get seriously ill or even die from pneumonia? It turns out the cause may have as much to do with the gut as it does with the lungs.
- The Link Between Inflammation, Infection, and DVTon May 3, 2022 at 5:00 pm
pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study.” Circulation Research: “Inflammation, Infection and Venous Thromboembolism.” ...
- Administration of a lipid reduces inflammation associated with multiple sclerosis in miceon April 26, 2022 at 11:28 pm
Acute inflammation is a protective response to ... persistent and plays a key role in the development of the disease. A research team led by Rubén López-Vales, Professor of Physiology at the ...
via Bing News